Table 2.

Results From 3 Analytic Approaches Used to Identify Predictors of Mortality Among Human Immunodeficiency Virus-Infected Patients After Initiation of Antiretroviral Therapy, Mbarara, Uganda, 2004–2007^a

Factor	Unweighted			Inverse Probability of Censoring Weighted			Sampling-based Weighted
	OR	95% CI	P Value	OR	95% CI	P Value	OR	95% CI	P Value
Age, per 10 years	1.22	0.90, 1.65	0.19	1.23	0.91, 1.71	0.13	1.37	1.06, 1.77	0.02
Male sex	1.81	1.05, 3.11	0.03	1.87	1.07, 3.25	0.04	1.05	0.58, 1.88	0.88
Weight ≤40 kg at ART initiation	2.07	0.87, 4.96	0.10	2.17	0.92, 5.12	0.07	3.66	1.85, 7.27	0.00
Pretherapy CD4 cell count, cells/μL
≤50	1	Referent		1	Referent		1	Referent
51–100	0.70	0.32, 1.52	0.37	0.74	0.33, 1.69	0.48	0.46	0.20, 1.03	0.06
101–200	0.20	0.07, 0.59	0.00	0.32	0.12, 0.86	0.02	0.14	0.05, 0.45	0.00
>200	0.22	0.06, 0.76	0.02	0.37	0.11, 1.24	0.10	0.27	0.09, 0.80	0.02
Distance from home to clinic, per 10 km	0.92	0.84, 1.00	0.05	0.91	0.84, 1.01	0.07	1.00	0.93, 1.08	0.99
Pretherapy WHO stage 4	0.92	0.35, 2.40	0.86	1.13	0.45, 2.81	0.68	0.76	0.26, 2.25	0.62
Year of ART initiation
2004	1	Referent		1	Referent		1	Referent
2005	0.71	0.37, 1.37	0.31	0.51	0.25, 1.01	0.05	1.84	0.99, 3.42	0.05
2006	0.54	0.22, 1.30	0.17	0.42	0.20, 0.90	0.03	0.77	0.31, 1.96	0.59
2007	0.25	0.05, 1.15	0.07	0.15	0.04, 0.67	0.01	0.09	0.02, 0.43	0.00

Abbreviations: ART, antiretroviral therapy; CI, confidence interval; OR, odds ratio; WHO, World Health Organization.

^aResults for each factor were adjusted for all other factors in the table.